Ernexa Therapeutics ERNAW
NASDAQ ERNAW
$0.06 +0.01 (+25.27%)
As of: Sep 4, 2026 · 3:55 PM EDT

Ernexa Therapeutics (ERNAW) Divestments (2021)

Ernexa Therapeutics' (ERNAW) quarterly Divestments came in at $119000.0 in Q1 2021.

Analysis

Ernexa Therapeutics (ERNAW) Divestments (2021) Analysis & Trends

Ernexa Therapeutics (ERNAW) has 1 years of Divestments data on file, last reported at $119000.0 in Q1 2021.

  • Quarterly Divestments changed N/A year-over-year to $119000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $119000.0 (changed N/A YoY) and the FY2021 annual result came in at $119000.0, changed N/A from the prior year.
  • Divestments was little changed at $119000.0 in Q1 2021.
  • In the past five years, Divestments ranged from a high of $119000.0 in Q1 2021 to a low of $119000.0 in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -13.21 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Ernexa Therapeutics 67,312.70 67,312.70 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 119,000.00